Lignin nanoparticles (LNPs) were functionalized with the “mUNO” hexapeptide to target MR on TAMs, which resulted in a meaningful shift in the immune cells in the tumor microenvironment towards an anti-tumor immune state. Here, NR3C2 is linked to neoplasm.